Can a smartphone app curb teen suicide risk?
NCT ID NCT06454136
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This pilot study tests a mobile app designed to reduce suicidal thoughts in teenagers. It will enroll 228 teens aged 13-17 who were recently hospitalized for a suicide attempt or have a history of attempts. Participants will use either the experimental app or a standard information app, and researchers will measure changes in suicidal thinking over 12 weeks.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
mobile app (OTX-207)
What this could lead to
If it works, this could provide a scalable, accessible tool to help teens manage suicidal thoughts after a hospital stay.
What could go wrong
This is a small, early pilot study. The app may not reduce suicidal thoughts more than standard care, and results may not apply to all teens.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SUICIDAL IDEATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hartford HealthCare
Hartford, Connecticut, 06106, United States
-
Rhode Island/Bradley Hospital/Brown Health University
Providence, Rhode Island, 02903, United States
-
University of Cincinnati
Cincinnati, Ohio, 45219, United States